| Karlovits et al. 2011 [14] | 35 patients | Choroidal melanoma treated with iodine brachytherapy | Median 45 months | -- | -- | 6% | -- |
| Finger et al. 2012 [16] | 24 patients | Choroidal melanomas within 1.5 mm of optic disc treated with slotted radiotherapy | Mean 23 months | -- | -- | 0 (0.0%) | -- |
| Berry et al. 2013 [17] | 82 patients | Medium sized choroidal melanomas | Median 46.8 months | 2/82 (2.4%) | -- | -- | -- |
| Caminal et al. 2013 [18] | 54 patients | Choroidal melanoma treated with iodine brachytherapy | Mean 59.47 months | 1/54 (1.9%) | 6/54 (11.1%) | 7/54 (13.0%) | -- |
| Marconi et al. 2013 [31] | 94 patients | Choroidal melanoma treated with ruthenium brachytherapy | Median 39 months | 4/94 (4.3%) | 4/94 (4.3%) |
| -- |
| Sagoo et al. 2014 [32] | 650 eyes | Juxtapapillary choroidal melanoma | Median 40 months | -- | -- | 16% at 5 years | Plaque size, tumor recurrence, neovascular glaucoma, absence of nonproliferative retinopathy |
| Semenova et al. 2014 [20] | 47 patients | T3 or T4 sized choroidal melanomas treated with palladium brachytherapy | Median 47 months | 3/47 (6.4%) | 2/47 (4.3%) | -- | -- |